Iuri Drumond Louro

Prof. Dr. Iuri Drumond Louro

Center for Human and Molecular Genetics, Universidade Federal do Espírito Santo, Vitória 29500-000, Espírito Santo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2005 in Oncogene
Verified
Journal Article
Closed access
PDF file
KFK Wade Foster
K Wade Foster
ZLZhaoli Liu
Zhaoli Liu
CNClinton D Nail
Clinton D Nail
XLXingnan Li
Xingnan Li
TFThomas J Fitzgerald
Thomas J Fitzgerald
JRJ Michael Ruppert
J Michael Ruppert

1 June 1999
Verified
Journal Article
Closed access
KFK W Foster
K W Foster
SRS Ren
S Ren
ILIuri Drumond Louro
Iuri Drumond Louro
SLS M Lobo-Ruppert
S M Lobo-Ruppert
PMP McKie-Bell
P McKie-Bell
JRJ M Ruppert
J M Ruppert

28 June 2023 in Genes
Verified
Journal Article
Open access
PDF file
LALyvia Neves Rebello Alves
Lyvia Neves Rebello Alves
DMDébora Dummer Meira
Débora Dummer Meira
LMLuiza Poppe Merigueti
Luiza Poppe Merigueti
MCMatheus Correia Casotti
Matheus Correia Casotti
DVDiego Ventorim
Diego Ventorim
ILIuri Drumond Louro
Iuri Drumond Louro
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for breast cancer diagnosis, prognosis, and risk prediction, enabling personalized treatments, improving therapy, and preventing overtreatment, undertreatment, and incorrect treatment. Several breast cancer biomarkers have been identified and, along with traditional biomarkers, they can assist physicians throughout treatment plan and increase therapy success. Despite the need of more data to improve specificity and determine the real clinical utility of some biomarkers, others are already established and can be used as a guide to make treatment decisions. In this review, we summarize the available traditional, novel, and potential biomarkers while also including gene expression profiles, breast cancer single-cell and polyploid giant cancer cells. We hope to help physicians understand tumor specific characteristics and support decision-making in patient-personalized clinical management, consequently improving treatment outcome.

27 March 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PAPriscila Marinho de Abreu
Priscila Marinho de Abreu
ACAnna Clara Gregório Có
Anna Clara Gregório Có
PAPedro Leite Azevedo
Pedro Leite Azevedo
IVIsabella Bittencourt Do Valle
Isabella Bittencourt Do Valle
KOKarine Gadioli de Oliveira
Karine Gadioli de Oliveira
Sandra Ventorin von ZeidlerSandra Ventorin von Zeidler
Sandra Ventorin von Zeidler
The prevalence of high-risk human papillomavirus (HPV) DNA in cases of oral cavity squamous cell carcinoma (SCC) varies widely. The aim of this study is to investigate the frequency of high-risk HPV DNA in a large Brazilian cohort of patients with oral cavity SCC. Biopsy and resected frozen and formalin-fixed paraffin-embedded specimens of oral cavity SCC were available from 101 patients who were recruited at two Brazilian centres. Stringent measures with respect to case selection and prevention of sample contamination were adopted to ensure reliability of the data. Nested PCR using MY09/MY11 and GP5+/GP6+ as well as PGMY09/11 L1 consensus primers were performed to investigate the presence of HPV DNA in the tumours. HPV-positive cases were subjected to direct sequencing. Shapiro–Wilk and Student t test were used to evaluate data normality and to compare the means, respectively. Qualitative variables were analysed by logistic regression. Our results demonstrate that the frequency of high-risk HPV types in oral cavity SCC is very low and is less than 4%. All HPV-positive cases were HPV16. In addition, our results do not show a significant association between the tumour clinical features and the risk factors (tobacco, alcohol and HPV) for oral cavity SCC. In the current study, we observed an overlapping pattern of risk factors that are related to tumour development. This, along with a low frequency of high-risk HPV DNA, supports the findings that HPV is not involved in the genesis of oral cavity SCC in Brazilian population.

11 July 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ESElaine Stur
Elaine Stur
Andres Felipe Aristizabal-PachonAndres Felipe Aristizabal-Pachon
Andres Felipe Aristizabal-Pachon
KPKamila Chagas Peronni
Kamila Chagas Peronni
LALidiane Pignaton Agostini
Lidiane Pignaton Agostini
SWSabine Waigel
Sabine Waigel
ILIuri Drumond Louro
Iuri Drumond Louro
Glyphosate is a broad-spectrum herbicide that is used worldwide. It represents a potential harm to surface water, and when commercially mixed with surfactants, its uptake is greatly magnified. The most well-known glyphosate-based product is Roundup. This herbicide is potentially an endocrine disruptor and many studies have shown the cytotoxicity potential of glyphosate-based herbicides. In breast cancer (BC) cell lines it has been demonstrated that glyphosate can induce cellular proliferation via estrogen receptors. Therefore, we aimed to identify gene expression changes in ER+ and ER- BC cell lines treated with Roundup and AMPA, to address changes in canonical pathways that would be related or not with the ER pathway, which we believe could interfere with cell proliferation. Using the Human Transcriptome Arrays 2.0, we identified gene expression changes in MCF-7 and MDA-MB-468 exposed to low concentrations and short exposure time to Roundup Original and AMPA. The results showed that at low concentration (0.05% Roundup) and short exposure (48h), both cell lines suffered deregulation of 11 canonical pathways, the most important being cell cycle and DNA damage repair pathways. Enrichment analysis showed similar results, except that MDA-MB-468 altered mainly metabolic processes. In contrast, 48h 10mM AMPA showed fewer differentially expressed genes, but also mainly related with metabolic processes. Our findings suggest that Roundup affects survival due to cell cycle deregulation and metabolism changes that may alter mitochondrial oxygen consumption, increase ROS levels, induce hypoxia, damage DNA repair, cause mutation accumulation and ultimately cell death. To our knowledge, this is the first study to analyze the effects of Roundup and AMPA on gene expression in triple negative BC cells. Therefore, we conclude that both compounds can cause cellular damage at low doses in a relatively short period of time in these two models, mainly affecting cell cycle and DNA repair.

15 October 2002
Verified
Journal Article
Closed access
ILIuri Drumond Louro
Iuri Drumond Louro
EBEvans C Bailey
Evans C Bailey
XLXingnan Li
Xingnan Li
LSLindsey S South
Lindsey S South
PMPeggy R McKie-Bell
Peggy R McKie-Bell
JRJ Michael Ruppert
J Michael Ruppert